InvestorsHub Logo
Followers 43
Posts 5432
Boards Moderated 0
Alias Born 11/15/2013

Re: quaerere post# 86598

Tuesday, 01/13/2015 11:53:03 AM

Tuesday, January 13, 2015 11:53:03 AM

Post# of 403061
Shorts are having a big day.. Negatives from bio conference FDA meeting to discuss Brilacidin Phase3 bottom line meeting went from December to at least 2 more months away. Uplisting went from on Leo's desk and soon to 2015. No discussion's of a partnership. We know Cellceutix is paying for Kevetrin testing and now it appears to have no end in sight. Money will soon become a real issue.IMO... Criticism welcomed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News